REEMA PATEL: Open Payments
NPI 1912768748 · GRAPEVINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 41 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $898 · 2025 $1,194
Food & beverage: $1,161Education: $32
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $257 |
| ABBVIE INC. | 5 | $185 |
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| Novo Nordisk Inc | 7 | $141 |
| Dexcom, Inc. | 2 | $141 |
| Lilly USA, LLC | 3 | $139 |
| Astellas Pharma US Inc | 4 | $67 |
| Amgen Inc. | 2 | $34 |
| Verity Pharmaceuticals Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $22 |
Products named: Auvelity, KISUNLA, UBRELVY, DEXCOM G7 GSS (161), BREZTRI, Ozempic, Veozah, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
